Cancer Research

Helix Receives Approval To Open Sites In Germany For Its Ongoing Clinical Trial With Topical Interferon Alpha-2b In Patients Wit

"HBP". For further information contact: Investor & Media Relations Ian Stone Russo Partners LLC Tel: ...

Article - Anna Ohlden - Sep 22 2008 - 7:31am

Bayer's Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence

the risk of one group developing a disease in comparison to the risk of another group. CONTACT FOR ...

Article - Anna Ohlden - Oct 2 2008 - 6:34am

Eco-teens Launch A Green Campaign

publications around the world. Contact Diana at spiritlinks@comcast.net. © by Diana deRegnier 2008 ...

Article - Diana Deregnier - Oct 13 2008 - 5:05pm

From Curiosity To Discovery: Boehringer Ingelheim's Pipeline Update Unveils Novel Investigational Compounds Heralding The Compan

authorities, BIBF 1120 is planned to be marketed under the trade name VARGATEF(R). Contact: Julia ...

Article - Anna Ohlden - Oct 17 2008 - 6:34am

Rosetta Genomics Reports Third Quarter 2007 Financial Results

Contact: Media Alan Zachary T: +1-312-944-6784 media@rosettagenomics.com Contact: Media: Alan Zachary, T: ...

Article - Anna Ohlden - Nov 8 2007 - 7:52am

Stonegate Report About Unigene Laboratories Inc.

garyzell@gmx.ch For further information please contact: Stonegate Securities, Inc. Laura S. Engel, Tel.: ...

Article - Anna Ohlden - Mar 13 2008 - 7:33am

Rosetta Genomics Reports First Quarter 2008 Financial Results

+1-646-509-1893 E: investors@rosettagenomics.com Contact: Media, Rachel Spielman, T: +1-212-583-2714, E: ...

Article - Anna Ohlden - May 21 2008 - 8:32am

Rosetta Genomics Reports Second Quarter 2008 Financial Results

E: media@rosettagenomics.com Contact: Investors, Joshua Gordon, M.D., T: +1-201-946-0561, E: ...

Article - Anna Ohlden - Aug 19 2008 - 4:32am

European Committee Issues Positive Opinion On Wyeth's TORISEL(TM) For Advanced Renal Cell Carcinoma

and close contact with those who received live vaccines should be avoided. Patients and their partners ...

Article - Anna Ohlden - Sep 20 2007 - 1:26pm

Raptor Pharmaceuticals Acquires Initial Clinical Program Establishes Subsidiary To Develop Clinical Phase Drugs

contact: The Ruth Group Sara Ephraim (investors) Janine McCargo (media) +1-646-536-7002 +1-646-536-7033 ...

Article - Anna Ohlden - Oct 22 2007 - 5:34am